71
Acral Lesions in Dermatopathology Janis M. Taube, MD Director of Dermatopathology Associate Professor, Dermatology and Pathology Johns Hopkins Medical Institutions

Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

  • Upload
    others

  • View
    5

  • Download
    1

Embed Size (px)

Citation preview

Page 1: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Acral Lesions in Dermatopathology

Janis M. Taube, MDDirector of Dermatopathology

Associate Professor, Dermatology and PathologyJohns Hopkins Medical Institutions

Page 2: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Overview• Non-neoplastic

– Circumscribed palmar hypokeratosis– Necrolytic acral erythema– TNF-alpha inhibitor reactions– Bullous acral erythema– APACHE

• Neoplastic– Soft tissue lesions– Miscellaneous

Page 3: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Overview• Non-neoplastic

– Circumscribed palmar hypokeratosis– Necrolytic acral erythema– TNF-alpha inhibitor reactions– Bullous acral erythema– APACHE

• Neoplastic– Soft tissue lesions– Miscellaneous

Page 4: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Circumscribed palmar/plantar hypokeratosis

• Clinically:– Round lesion with, very

well-defined borders and erythematous central area

– Tendency for thenar/hypothenar areas, medial side of sole

Page 5: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Histologic Features

– Well-demarcated decrease in thickness of stratum corneum

– Diminished granular layer– No inflammation

Page 6: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Background-- Only a few cases have been reported in the literature-- First described in 2002 (Perez, et al JAAD)-- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in

keratinization.

Treatment:-- Topical corticosteroids or topical retinoids are

ineffective

-- possible benefit form photodynamic therapy or calcipotriol treatment

Page 7: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

June 2013. Am J Dermpath

Page 8: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Necrolytic Acral Erythema

• Sharply-demarcated scaly plaques on dorsum of hands and feet

• Appox 50 patients reported since 1996

• Strong association with HCV

Page 9: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--
Page 10: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Histologic features

• Early lesions may show only psorasiformhyperplasia with scattered and grouped dyskeratotic cells

• Well-developed lesions include parakeratosis, neutrophils, hypogranulosis

Page 11: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Early lesion

Page 12: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--
Page 13: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--
Page 14: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Pustular folliculitis, psoriasis, interface dermatitis, neutrophilic eccrine hidradenitis, Sweet’s syndrome, lupus, vasculitis, and palmoplantar pustulosis

Page 15: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Palmoplantar pustulosis

Hawryluk et al. J Cutan Pathol, 2012

Page 16: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

• Variant of chemotherapy-induced acral erythema

• Acral dysthesia followed by erythema, blisters, and desquamation

• Approx 30 cases in literature

• Cytarabine and methotrexate most common drugs

Bullous acral erythema

Podjasek and Camilleri, J Cutan Pathol, 2012

Page 17: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Histologic features

Pauci-inflammatory, subepidermal bullae, DIF-negative

Page 18: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Acral pseudolymphomatousangiokeratoma of children (APACHE)

Page 19: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Acral pseudolymphomatousangiokeratoma of children (APACHE)

Fonia, et al. Clin Exper Derm, 2016. 41(7), 751-3.

• APACHE likely represents a spectrum of benign lesions in adults in children

• Multiple, hyperkeratotic erythematous/violaceous papules and nodules that are usually asymptomatic

• Predilection for acral sites

• Etiology unknown

Page 20: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Acral pseudolymphomatousangiokeratoma of children (APACHE)

Subepidermal, dense lymphoid infiltrate. Often proliferation of thick-walled blood vessels.

Fonia, et al. Clin Exper Derm, 2016. 41(7), 751-3.

Page 21: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Acral pseudolymphomatousangiokeratoma of children (APACHE)

Fonia, et al. Clin Exper Derm, 2016. 41(7), 751-3.

Predominantly T-cells (mixed CD4 and CD8) with scattered B-cells.

Page 22: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

APACHE Proposed alternate name: T‐cell‐rich angiomatoid polypoid pseudolymphoma of the skin

J Cutan Pathol, 2011; 38, 6: 475-82

Page 23: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Overview• Non-neoplastic

– Circumscribed palmar hypokeratosis– Necrolytic acral erythema– TNF-alpha inhibitor reactions– Bullous acral erythema– APACHE

• Neoplastic– Soft tissue lesions– Miscellaneous

Page 24: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Soft Tissue Lesions• Superficial acral fibromyxoma (aka digital fibromyxoma)• Cellular digital fibroma• Lipofibromatosis• DFSP• Myxoinflammatory fibroblastic sarcoma (aka inflammatory

myxohyaline tumor of distal extremities)• EWSR1-SMAD3-rearranged fibroblastic tumor• Perineurioma• Clear cell sarcoma• Myoepithelioma/myoepithelial carcinoma

Page 25: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

• 37 cases from 25 m and 12 f, age 14-72• toe [20 cases], finger [13], palm [4]• nail region often affected [16 cases]• 1-5 cm, usually well-delimited• dermal

Human Pathol 2001.

Page 26: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Histologic features• Moderate cellularity, possible

focal cytologic atypia, but low mitotic activity

• Stellate to spindled firboblasts in myxoid to collagenous stroma

• Minimal inflammation, except mast cells

• EMA, CD34, CD99• NEGATIVE muscle markers,

keratins, S100 protein, HMB45

• Occasional recurrences

Page 27: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

CD34

DDx:• Myxoid DFSP• Myxoid NF• Digital myxoid

pseudocyst• Myxoinflammatory

fibroblastic sarcoma• Myxoid MFH

Page 28: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

“intersecting

“intersecting fascicles of relatively bland CD34-positive spindle cells in fibrous or fibromyxoid stroma”

Page 29: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

• 45 tumors from 32 boys and 12 girls, 11d-12y

• Hand [18 cases], arm [8], leg [7], foor [6], chest [3], abdomen [2], head [1]

• 8 congenital• painless, slow-growing

Lipofibromatosis

Page 30: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Lipofibromatosis

• 1-7 cm, poorly marginated, infiltrative

• Abundant fat with accompanying fibroblastic proliferation

• Spindled areas with CD34, CD99, SMA variably bcl-2, S100, MSA

• Recurrences common

Page 31: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--
Page 32: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Cells reminiscent of lipoblasts in zones where fat and fibroblastic component merge

Page 33: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Dermatofibrosarcoma Protuberans

• Usually young adults• Recent case series (n=27) on distal extremities and acral sites• CD34+ by IHC• COL1A1-PDGFB gene fusion

Shah K, et al. Dermatofibrosarcoma Protuberans of Distal Extremities and Acral Sites: A Clinicopathologic Analysis of 27 Cases. 2018

Page 34: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Myxoinflammatory fibroblastic scarcoma

Page 35: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Inflammatory myxohyaline tumor of distal extremities with virocyte or Reed-Sternberg-like cells: A distinctive lesion with features simulating inflammatory conditions, Hodgkin’s disease, and various sarcomas. Montgomery EA, Devaney KO, Giordano TJ, Weiss SW

Modern Pathology 1998; 11: 384-91.

Acral myxoinflammatory fibroblastic sarcoma. A low grade tumor of the hands and feet

Meis-Kindblom JM, Kindblom L-G.Am J Surg Pathol 1998; 22: 911-24.

2002 WHO name: Myxoinflammatory fibroblastic scarcoma

Page 36: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Clinical Features

• All ages: range 4-91 yrs (median 45 years)• No sex predilection• Non-tender mass on an extremity (70%

upper and 30% lower)• Recurrence rates vary from 6-67%• Lymph node metastases have been reported

Page 37: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Myxoinflammatory fibroblastic scarcomaTumor Depth

Tendon 35%Synovium 20%Subcutis 45%

Page 38: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--
Page 39: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Histologic features• Dense chronic

inflammatory infiltrate

• Myxomatousadjacent to hyalinized stroma

• Collections of short spindled and rounded epithelioidcells

Page 40: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

• Epithelioid cells may have large, bizarre cells with macronucleoli• Low mitotic index• Lesional cells express CD34, EGFR, and CD163

Page 41: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--
Page 42: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Kovarik C, et al J Cutan Pathol 2008

Page 43: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

New Observation

Page 44: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--
Page 45: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Michal et al. Am J Surg Path. 2018. 42(10):1325-33.

Page 46: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

2

ERGMichal et al. Am J Surg Path. 2018. 42(10):1325-33.

Page 47: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Perineurioma

Page 48: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Sclerosing perineurioma

• Children and young adults• Well-circumscribed dermal or subcutaneous

nodules on hands (including palms)

Journal of Cutaneous Pathologypages 60-65, 27 JAN 2009

Page 49: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--
Page 50: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Epithelioid and spindle cells with wavy nuclei, elongated cytoplasmic processesDense collagenous stroma

Page 51: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Journal of Cutaneous Pathologypages 60-65, 27 JAN 2009

Page 52: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Perineurioma, EMA

EMA (100%) CD34 (65%), Glut 1

Page 53: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--
Page 54: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Clear Cell Sarcoma

• Young adults, 3rd to 4th decade• 40% involve foot/ankle• Slow-growing lesion• t[12;22] with EWS ATF1 fusion• 37% - 59% mortality • Nodal mets in 50%

Page 55: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--
Page 56: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--
Page 57: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--
Page 58: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Myoepithelioma

• Recently described in the skin• Painless cutaneous nodule• Involving extremity• Younger patients (22 yrs median age)

Page 59: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Histologic features

• Epithelioid cells with scant eosinophiliccytoplasm

• Solid, spindled, plasmacytoid, and combinations

• Stroma may vary• CK+, S100+, and SMA+

Page 60: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--
Page 61: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

S100 AE1/3

Page 62: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Myoepithelial Carcinoma

• No criteria for malignancy in cutaneous lesions

• Presence of cytologicatypia and increased mitotic index are most important factors

Page 63: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Overview• Non-neoplastic

– Circumscribed palmar hypokeratosis– Necrolytic acral erythema– TNF-alpha inhibitor reactions– Bullous acral erythema– APACHE

• Neoplastic– Soft tissue lesions– Miscellaneous

Page 64: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Digital Papillary Adenoma/Adenocarcinoma

Page 65: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

• Strong male predominance• Mean age 43 yrs• All involved a finger or toe, with most involving the

distal part of the digit• Subcutaneous extension in 50% of cases• Histologic features (including presence of

myoepithelial cells) not predictive of outcome

Page 66: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--
Page 67: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

H&E H&E

CD8 TIA

Page 68: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Primitive non-neural granular cell tumor (PNGCT)

• 1991 Leboit et al “primitive polypoid granular cell tumor (GCT)”• Two larger series as “PNGCT” and “dermal non-neural GCT” • Not neural or Schwannian in origin, but line of differentiation

remains unknown• Solitary painless nodule most typically on extremity of adult• Typically benign, but one report of a lymph node metastasis has

been documented

Page 69: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Histologic features

• Relatively circumscribed• No well-developed PEH• Mitotic index from 1-3

per mm2 with occasional atypical forms

• S100-, CD68+, NKI-C3+• EM confirmed

lysosomes

Lewin, et al. J Cutan Pathol, 2011

Page 70: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Congenital epulis of the newborn

• S100-negative epithelioid granular cells

• Usually involves the alveolar ridge of females

Page 71: Acral Lesions in Dermatopathology€¦ · -- Clinical DDx includes porokeratosis or Bowen disease-- Authors consider it a chronic localized defect in keratinization. Treatment:--

Suggested reference:

Chalhoub and Al-Rohil, 10 Jan 2019, J Cutan PatholTable showing DDx of spindle cell tumors on acral sites